Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | February 25, 2022 09:10am

 

Gainers

  • Kaleido Biosciences (NASDAQ:KLDO) stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6 million.
  • Iterum Therapeutics (NASDAQ:ITRM) stock rose 14.24% to $0.39. The company's market cap stands at $70.3 million.
  • Creative Medical Tech (NASDAQ:CELZ) stock rose 10.38% to $2.02. The market value of their outstanding shares is at $12.7 million.
  • Also check out: Executives Buy Around $1M Of 5 Penny Stocks
  • Aerie Pharmaceuticals (NASDAQ:AERI) shares moved upwards by 10.16% to $6.5. The market value of their outstanding shares is at $307.8 million. As per the press release, Q4 earnings came out yesterday.
  • Aquestive Therapeutics (NASDAQ:AQST) shares increased by 8.87% to $2.7. The company's market cap stands at $108.4 million.
  • Axcella Health (NASDAQ:AXLA) stock rose 7.95% to $1.9. The market value of their outstanding shares is at $73.9 million.

 

Losers

  • Baudax Bio (NASDAQ:BXRX) shares declined by 54.3% to $2.0 during Friday's pre-market session. The company's market cap stands at $4.8 million.
  • Midatech Pharma (NASDAQ:MTP) shares decreased by 15.29% to $0.82. The company's market cap stands at $10.3 million.
  • Cardiff Oncology (NASDAQ:CRDF) shares fell 13.86% to $2.3. The market value of their outstanding shares is at $96.5 million. The company's, Q4 earnings came out yesterday.
  • Synlogic (NASDAQ:SYBX) stock declined by 13.05% to $1.6. The market value of their outstanding shares is at $111.5 million.
  • OPKO Health (NASDAQ:OPK) shares declined by 12.7% to $2.82. The company's market cap stands at $1.9 billion. As per the press release, Q4 earnings came out yesterday.
  • Clearside Biomedical (NASDAQ:CLSD) shares declined by 10.96% to $1.3. The market value of their outstanding shares is at $77.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AERI AQST AXLA BXRX CELZ CLSD CRDF ITRM KLDO MTP OPK SYBX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist